Bulgaria vs Iceland: Hepatitis B surface antigen (HBsAg) prevalence
Bulgaria
0.0%
in 2024
Iceland
0.0%
in 2024
Bulgaria rank
132nd
Iceland rank
132nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Bulgaria
- Iceland
How they compare
Bulgaria currently reports 0.0% against 0.0% in Iceland, a difference of 0.0%.
Across all 10 years both countries report, Iceland has been ahead every year.
Bulgaria ranks 132nd and Iceland ranks 132nd of 194 countries.
Iceland has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Bulgaria | Iceland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.0% | 0.1% | 0.1% | Iceland |
| 2020s | 0.0% | 0.0% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Bulgaria or Iceland?
- Bulgaria, at 0.0% against 0.0% in Iceland as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Bulgaria and Iceland?
- 0.0%, with Bulgaria ahead.
- How many years of comparable data are there for Bulgaria and Iceland?
- 10 years are reported by both, from 2015 to 2024.
- How do Bulgaria and Iceland rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Bulgaria ranks 132nd and Iceland ranks 132nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.